Cargando…

Hydrophobic Interactions Drive Binding between Vascular Endothelial Growth Factor-A (VEGFA) and Polyphenolic Inhibitors

Some polyphenols have been shown to inhibit, at physiological levels, the VEGF-induced VEGF receptor-2 signaling that causes angiogenesis, allegedly by direct interaction with VEGF and reducing the binding to its receptor VEGFR2. Surface plasmon resonance was used to measure the parameters of bindin...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez-Moral, Natalia, Needs, Paul W., Moyle, Christina W.A., Kroon, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695681/
https://www.ncbi.nlm.nih.gov/pubmed/31370204
http://dx.doi.org/10.3390/molecules24152785
_version_ 1783444092337782784
author Perez-Moral, Natalia
Needs, Paul W.
Moyle, Christina W.A.
Kroon, Paul A.
author_facet Perez-Moral, Natalia
Needs, Paul W.
Moyle, Christina W.A.
Kroon, Paul A.
author_sort Perez-Moral, Natalia
collection PubMed
description Some polyphenols have been shown to inhibit, at physiological levels, the VEGF-induced VEGF receptor-2 signaling that causes angiogenesis, allegedly by direct interaction with VEGF and reducing the binding to its receptor VEGFR2. Surface plasmon resonance was used to measure the parameters of binding between VEGF and polyphenols as well as the nature of the interactions by assessing the effect of physico-chemical changes in the solution. CD spectrometry was used to determine any change in the secondary structure of the protein upon binding. The kinetic parameters (k(a), k(d), and K(D)) that characterise the binding to VEGF were measured for both inhibitor and non-inhibitor polyphenolic molecules. The effect of changes in the physico-chemical conditions of the solution where the binding occurred indicated that the nature of the interactions between VEGF and EGCG was predominantly of a hydrophobic nature. CD studies suggested that a change in the secondary structure of the protein occurred upon binding. Direct interaction and binding between VEGF and polyphenol molecules acting as inhibitors of the signaling of VEGFR2 has been measured for the first time. The binding between VEGF and EGCG seemed to be based on hydrophobic interactions and caused a change in the secondary structure of the protein.
format Online
Article
Text
id pubmed-6695681
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66956812019-09-05 Hydrophobic Interactions Drive Binding between Vascular Endothelial Growth Factor-A (VEGFA) and Polyphenolic Inhibitors Perez-Moral, Natalia Needs, Paul W. Moyle, Christina W.A. Kroon, Paul A. Molecules Article Some polyphenols have been shown to inhibit, at physiological levels, the VEGF-induced VEGF receptor-2 signaling that causes angiogenesis, allegedly by direct interaction with VEGF and reducing the binding to its receptor VEGFR2. Surface plasmon resonance was used to measure the parameters of binding between VEGF and polyphenols as well as the nature of the interactions by assessing the effect of physico-chemical changes in the solution. CD spectrometry was used to determine any change in the secondary structure of the protein upon binding. The kinetic parameters (k(a), k(d), and K(D)) that characterise the binding to VEGF were measured for both inhibitor and non-inhibitor polyphenolic molecules. The effect of changes in the physico-chemical conditions of the solution where the binding occurred indicated that the nature of the interactions between VEGF and EGCG was predominantly of a hydrophobic nature. CD studies suggested that a change in the secondary structure of the protein occurred upon binding. Direct interaction and binding between VEGF and polyphenol molecules acting as inhibitors of the signaling of VEGFR2 has been measured for the first time. The binding between VEGF and EGCG seemed to be based on hydrophobic interactions and caused a change in the secondary structure of the protein. MDPI 2019-07-31 /pmc/articles/PMC6695681/ /pubmed/31370204 http://dx.doi.org/10.3390/molecules24152785 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Perez-Moral, Natalia
Needs, Paul W.
Moyle, Christina W.A.
Kroon, Paul A.
Hydrophobic Interactions Drive Binding between Vascular Endothelial Growth Factor-A (VEGFA) and Polyphenolic Inhibitors
title Hydrophobic Interactions Drive Binding between Vascular Endothelial Growth Factor-A (VEGFA) and Polyphenolic Inhibitors
title_full Hydrophobic Interactions Drive Binding between Vascular Endothelial Growth Factor-A (VEGFA) and Polyphenolic Inhibitors
title_fullStr Hydrophobic Interactions Drive Binding between Vascular Endothelial Growth Factor-A (VEGFA) and Polyphenolic Inhibitors
title_full_unstemmed Hydrophobic Interactions Drive Binding between Vascular Endothelial Growth Factor-A (VEGFA) and Polyphenolic Inhibitors
title_short Hydrophobic Interactions Drive Binding between Vascular Endothelial Growth Factor-A (VEGFA) and Polyphenolic Inhibitors
title_sort hydrophobic interactions drive binding between vascular endothelial growth factor-a (vegfa) and polyphenolic inhibitors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695681/
https://www.ncbi.nlm.nih.gov/pubmed/31370204
http://dx.doi.org/10.3390/molecules24152785
work_keys_str_mv AT perezmoralnatalia hydrophobicinteractionsdrivebindingbetweenvascularendothelialgrowthfactoravegfaandpolyphenolicinhibitors
AT needspaulw hydrophobicinteractionsdrivebindingbetweenvascularendothelialgrowthfactoravegfaandpolyphenolicinhibitors
AT moylechristinawa hydrophobicinteractionsdrivebindingbetweenvascularendothelialgrowthfactoravegfaandpolyphenolicinhibitors
AT kroonpaula hydrophobicinteractionsdrivebindingbetweenvascularendothelialgrowthfactoravegfaandpolyphenolicinhibitors